Literature DB >> 18402323

[Low complication rate with cataract operations carried out by registrars in ophthalmology].

M C A Pot1, J S Stilma.   

Abstract

OBJECTIVE: To determine the complication rate of cataract operations and learning curve of registrars in ophthalmology.
DESIGN: Retrospective, descriptive investigation.
METHOD: 982 consecutive cataract operations performed by registrars in ophthalmology at University Medical Centre Utrecht and the Meander Medical Centre, Amersfoort, the Netherlands, were evaluated for complications. Of patients in whom a complication occurred, the nature of the complication, any possible follow-up operation, and best corrected visual acuity before and following operation were assessed, as well as the stage of training the registrar was at.
RESULTS: The most important complications occurred in the following frequencies: endophthalmitis 0%, posterior capsule rupture with vitreous loss 1.32%, dropped nucleus 0.2%. Four patients required a second operation. There were no statistically significant differences in complication rate between the three phases of the training. In all patients with complications the best corrected visual acuity was more than 0.5.
CONCLUSION: The complication rate was smaller than described in the literature and comparable with rates known for ophthalmologists. Training in cataract surgery does not lead to irresponsible risks for the cataract patient. The combination of training in both a university hospital and a general hospital has several advantages for a registrar in ophthalmology.

Entities:  

Mesh:

Year:  2008        PMID: 18402323

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

1.  External ocular surface bacterial isolates and their antimicrobial susceptibility patterns among pre-operative cataract patients at Mulago National Hospital in Kampala, Uganda.

Authors:  Barnabas Mshangila; Musana Paddy; Henry Kajumbula; Charles Ateenyi-Agaba; Binta Kahwa; Jeremiah Seni
Journal:  BMC Ophthalmol       Date:  2013-11-15       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.